AXL receptor tyrosine kinase as a therapeutic target in NSCLC
Ross A Okimoto,1 Trever G Bivona1,2 1Division of Hematology and Medical Oncology, University of California San Francisco, San Francisco, CA, USA; 2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA Abstract: The AXL receptor tyrosine kina...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/66beb47003984936bec97fbf70841834 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|